New Production of Cancer Drugs in Ukraine
Ukraine is entering a new phase in the production of drugs to combat cancer diseases.
According to the press service of the State Enterprise "Medical Procurement" on Facebook, an agreement with the international pharmaceutical company Roche to localize the production of innovative cancer medications was signed during the Ukraine Recovery Conference 2025 in Rome.
"For the first time, our state enterprise becomes a full-fledged partner of a global leader in the development of innovative drugs! According to the investment agreement, the Swiss international company Roche will supply Ukraine with medications in bulk – that is, ready for packaging. Our branch 'Medpostachannya' will carry out the final packaging, labeling, and delivery to patients," the statement said.
This will significantly reduce the cost of drugs and, accordingly, increase the number of patients receiving modern treatment.
"According to Roche’s estimates, over the course of 5 years, the signed investment agreement will provide medications for more than 5,800 patients," the State Enterprise "Medical Procurement" noted.
In particular, they will procure drugs for the two most common types of cancer in Ukraine:
- Atezolizumab (“Tecentriq”) — for the treatment of non-small cell lung cancer;
- Pertuzumab + Trastuzumab (“Phesgo”) — for the treatment of HER2-positive breast cancer.
The first Ukrainian patients will be able to receive drugs with localized production as early as 2027.
This collaboration will result in significant cost reductions for medications, the development of pharmaceutical manufacturing in Ukraine, and sustainable access to treatment.
On July 10-11, the fourth International Conference on Ukraine Recovery (URC2025) is taking place in Rome, attended by the President of Ukraine and heads of European states.
The forum will continue a series of high-level political events focused on rapid recovery and long-term reconstruction of Ukraine, suffering from external aggression. This time, the Ukrainian delegation will focus on practical projects that are already being implemented even in wartime or are highly prepared for implementation.
